More than 80% of patients with type 2 diabetes mellitus develop hypertension, and approx.
20% of patients with hypertension develop diabetes. This combination of cardiovascular risk …

Background—Experimental studies revealed proinflammatory properties of angiotensin II.
We evaluated antiinflammatory effects of the angiotensin II subtype 1 receptor antagonist …

Abstract Objective Homocysteine (Hcy) is known as an independent risk factor for
atherosclerosis. C-reactive protein (CRP) directly participates in initiation and progression of …

During the past decade, the role of inflammation in the pathophysiology of arterial
thrombosis has been elucidated. However, comparatively little is known about the …

Background—Plasma C-reactive protein (CRP) concentration is a strong predictor of
atherosclerosis. However, to date, there is no in vivo evidence that CRP is proatherogenic …

The classical acute-phase protein, C-reactive protein (CRP), is an exquisitely sensitive
systemic marker of disease with broad clinical utility for monitoring and differential diagnosis …

C-reactive protein is postulated to embody an index that can reflect cardiovascular risk and
can be used to independently predict major cardiovascular events and mortality. On the …

First identified as a powerful vasoconstrictor, endothelin has an extremely diverse set of
actions that influence homeostatic mechanisms throughout the body. Two receptor subtypes …

Study objectives COPD is a systemic disorder that is associated with increases of
inflammatory proteins in systemic circulation. However, no data on the potential role of …

Systemic inflammation is present in chronic obstructive pulmonary disease (COPD), which
has been linked to cardiovascular morbidity and mortality. We determined the effects of oral …